AQP4 and multiple sclerosis: Although it had long been debated whether NMOSD is a severe variant of multiple sclerosis (MS), the discovery of NMOSD-specific aquaporin 4 (AQP4) antibody, and the subsequent clinical, immunological, and pathological data have established that NMOSD is indeed a distinct entity (1–3).